Weiss W R, Sedegah M, Beaudoin R L, Miller L H, Good M F
Laboratory of Parasitic Diseases, National Institutes of Health, Bethesda, MD 20892.
Proc Natl Acad Sci U S A. 1988 Jan;85(2):573-6. doi: 10.1073/pnas.85.2.573.
In recent malaria sporozoite vaccine trials in humans and mice, antibodies to the sporozoite coat protein have given only modest protection against sporozoite challenge. In contrast, irradiated sporozoites can protect mice against massive sporozoite infections. Evidence suggests that immunity in these mice is mediated by T cells. To identify the mechanism of immunity, we used monoclonal antibodies specific for either the CD4 or CD8 molecule to selectively deplete sporozoite-immunized mice of T-cell subsets. Though in vivo depletion of CD4+ T cells did not reduce immunity, depletion of CD8+ T cells abolished protection. Monoclonal antibody treatment did not affect anti-sporozoite antibody levels. Our data indicate that cytotoxic T cells are critical for immunity to large numbers of sporozoites and suggest that vaccine development should be reoriented toward stimulating cellular as well as humoral immunity.
在近期针对人类和小鼠的疟疾子孢子疫苗试验中,针对子孢子表面蛋白的抗体仅能提供适度的保护,抵御子孢子攻击。相比之下,经辐射的子孢子可保护小鼠免受大量子孢子感染。有证据表明,这些小鼠的免疫力是由T细胞介导的。为确定免疫机制,我们使用了针对CD4或CD8分子的单克隆抗体,以选择性地耗尽子孢子免疫小鼠的T细胞亚群。尽管体内耗尽CD4+T细胞并未降低免疫力,但耗尽CD8+T细胞则消除了保护作用。单克隆抗体治疗并未影响抗子孢子抗体水平。我们的数据表明,细胞毒性T细胞对抵御大量子孢子的免疫至关重要,并提示疫苗开发应重新转向刺激细胞免疫和体液免疫。